Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BPTH

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Bio Path Holdings Inc

BPTH
Current price
0.16 USD -0.005 USD (-3.09%)
Last closed 0.16 USD
ISIN US09057N3008
Sector Healthcare
Industry Biotechnology
Exchange OTCQX
Capitalization 1 412 341 USD
Yield for 12 month -91.42 %
1Y
3Y
5Y
10Y
15Y
BPTH
21.11.2021 - 28.11.2021

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. The company's lead drug candidate is the Prexigebersen (BP1001), which is in phase 2 clinical trial for the treatment of untreated acute myeloid leukemia (AML). It is also developing BP1001-A, which is in phase 1 clinical trial for treatment of solid tumors, including ovarian, endometrial and pancreatic cancer, as well as in preclinical trial to treat obesity and related metabolic diseases; Liposomal Bcl-2 (BP1002), which is in phase 1 clinical trial to treat refractory/relapsed lymphoma and refractory/relapsed chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003), which is preclinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and AML. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.00 USD

P/E Ratio

0.47

Dividend Yield

Financials BPTH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-178 000 USD

Current Quarter

Last Quarter

EBITDA -11 505 000 USD
Operating Margin TTM
Price to Earnings 0.47
Return On Assets TTM -363.93 %
PEG Ratio
Return On Equity TTM -3 325.71 %
Wall Street Target Price 2.00 USD
Revenue TTM
Book Value -0.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share 0.36 USD
Diluted Eps TTM 0.36 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation BPTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.47
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.025
Price Book MRQ 1.90

Technical Indicators BPTH

For 52 Weeks

0.12 USD 1.98 USD
50 Day MA 0.18 USD
Shares Short Prior Month 180 963
200 Day MA 0.54 USD
Short Ratio 0.43
Shares Short 79 346
Short Percent 1.38 %